Advani, Ranjana
Mayo Clinic
From the Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom (J.R.); BC Cancer Centre for Lymphoid Cancer, Va
Citations 1
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Ansell, Stephen M. , Radford, John , Kim, Won-Seog, Gallamini, Andrea , Ramchandren, Radhakrishnan , Friedberg, Jonathan W. , Advani, Ranjana H. , Hutchings, Martin , Evens, Andrew M. , Smolewski, Piotr , Bartlett, Nancy L. , Eom, Hyeon‐Seok , Dong, Cassie, Campana, Frank, Fenton, Keenan , Puhlmann, Markus , Straus, David J. , Długosz-Danecka, Monika, Advani, Ranjana, Evens, Andrew M , Bartlett, Nancy L , Advani, Ranjana H , Radford, John , Connors, Joseph M. , Długosz‐Danecka, Monika , Savage, Kerry J. , Abramson, Jeremy S.
New England Journal of Medicine | July 13, 2022 | Volume: 387 | Issue: 4 | Pages: 310-320
